KIR3DL1 and acute leukemia: Findings from a large study by the European Society for Blood and Marrow Transplantation (EBMT) involving patients with acute leukemia contradicted earlier observations, revealing that KIR/ligand mismatch was linked to a higher relapse risk and inferior OS [93].